Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pan-RAF kinase inhibitor MLN2480
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C28001, NCI-2013-00851, 13/SC/0007, 2012-003397-16, U1111-1164-7508, NCT01425008
A Phase 1B Study of MLN2480 in Combination With MLN0128 or Alisertib or Paclitaxel in Adult Patients With Advanced Nonhematologic Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C28002, NCI-2015-01108, 2014-003340-12, U1111-1159-5831, NCT02327169
Start Over